MedTrace Logo

Sleep, Exercise, Nutrition and Survivorship in Prostate Cancer

NCT05318131 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-09-19

No results posted yet for this study

Summary

The primary objectives of this study are to examine sleep, exercise, and nutrition in prostate cancer.

Conditions

Interventions

OTHER

Sleep and Lifestyle Advice Website

Participants will be asked to view a website at least once a week for 3 months (remotely). The website includes information about exercise, nutrition and sleep. Participants will also have a check-in call with a health coach at 6 weeks, and will be sent email newsletters at approximately 1 and 2 months with additional information about sleep, nutrition, and exercise.

OTHER

Surveys and Sleep Monitors

At baseline and at 3 months, participants will be asked to complete online surveys and to wear an ActiGraph sleep monitor for one week. ActiGraph sleep monitors are wristbands that measure continuous sleep/wake activity information. The recorded ActiGraph data is deidentified and no individual personally identifiable information is collected. A unique serial number identifies each wrist monitor. At the end of the study, participants will also have a telephone exit interview with the study team to provide feedback on their progress during the study and about the website.

Sponsors & Collaborators

  • New York State Department of Health

    collaborator OTHER_GOV

  • NYU Langone Health

    lead OTHER

Principal Investigators

  • Stacy Loeb, MD MSc · NYU Langone Health

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-30
Primary Completion
2023-09-26
Completion
2023-10-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05318131 on ClinicalTrials.gov